Abstract
This review presents analysis of the literature and our own research with respect to the role of miRNAs in the regulation of activity (expression) of genes controlling cellular homeostasis in human cells when exposed to ionizing radiation. Human cells, on one hand, can have increased resistance to radiation, which hinders the effectiveness of tumor treatment in radiotherapy. On the other hand, increased sensitivity to radiation may be accompanied by the development of several pathologies, including tumorigenesis. This paper examines the role of specific miRNAs in the formation of radioresistance and radiosensitivity of human cells and their impact on the respective target genes. Separate sections are devoted to the role of different miRNAs in radiation therapy of tumors of different localization, as well as their role in the bystander effect. A special section highlights features of gene activity and its regulators, miRNAs, in radiosensitive cells in patients with Down syndrome. The final section provides information about new approaches to change miRNA expression and, accordingly, their target genes by the action of plant and synthetic drugs (crown compounds) which reduce damaging effects of mutagens. It is assumed that antimutagens affecting the expression levels of miRNAs and structural genes may be used to correct the increase and decrease in cellular radioresponse, reducing the risk of development of pathological processes, including tumorigenesis.
Similar content being viewed by others
References
Brenner, D. and Hall, E., Computed tomography–an increasing source of radiation exposure, New Engl. J. Med., 2007, vol. 357, pp. 2277–2284.
Lowe Xin, Bhattacharya, S., Marchetti, F., et al., Early brain response to low–dose radiation exposure involved molecular networks and pathways associated with cognitive functions, advanced aging and Alzheimer, sdisease, Rad. Res., 2009, vol. 171, pp. 53–65.
Olial, C. and Li-Xi Yang, Radioprotectans to reduce the risk of radiation-induced carcinogenesis, Int. J. Rad. Biol., 2014, vol. 90, no. 3, pp. 203–213.
Yen, P., Lin, I., Chang, W., et al., Risk factors of depression after prolonged low-dose rate environmental radiation exposure, Int. J. Rad. Biol., 2014, vol. 90, no. 10, pp. 854–866.
Druzhinin, V.G., Volkov, V.A., Glushkov, A.N., et al., The role of polymorphisms of genes reparations in assessing the human genome sensitivity to the effects of excessive radon concentrations, Gig. Sanit., 2011, no. 5, pp. 26–30.
Jeggo, P., The role of DNA damage response mechanisms after low–dose radiation exposure and a consideration of potentially sensitive individual, Rad. Res., 2010, vol. 174, pp. 825–832.
Korpela, E., Vesprini, D., and Lin, S., MicroRNA in radiotherapy: miRage or miRador?, Br. J. Cancer, 2015, vol. 112, pp. 777–782.
Braga, E.A., Khodyrev, D.S., Loginov, V.I., et al., Methylation in the regulation of the expression of chromosome 3 and microRNA genes in clear-cell renal cell carcinomas, Russ. J. Genet., 2015, vol. 51, no. 6, pp. 566–581.
Metheetrairut, C. and Slank, F., MicroRNA in the ionizing radiation response and in radiotherapy, Curr. Opin. Genet. Dev., 2013, vol. 23, pp. 12–19.
Cellini, F., Morganti, A., Gorovesi, D., et al., Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy, Molecules, 2014, vol. 19, pp. 5379–5401.
Gandellini, P., Rancati, T., Valdagni, R., et al., MicroRNAs in tumor radiation response: bystanders or participants?, Trends Mol. Med., 2014, vol. 20, no. 9, pp. 529–539.
Friedman, R., Farh, K., Burge, C., et al., Most mammalian mRNA are conserved targets of micro RNAs, Genome Res., 2009, vol. 19, pp. 92–105.
Yu, Q., Li, B., Li, P., et al., Plasma microRNA to predict the response of radiotherapy in esophageal squamous cell carcinoma patients, Am. J. Transl. Res., 2015, vol. 7, pp. 2060–2070.
Czochor, J.R. and Glazer, P.M., MicroRNAs in cancer cells response to ionizing radiation, Antioxid. Redox Signaling, 2014, vol. 21, no. 2, pp. 293–312.
Barjaktarovic, Z., Anastasov, N., Azimzadeh, A., et al., Integrative proteomic and microRNA analysis of primary human coronary artery endothelial cells exposed to low-dose gamma radiation, Rad. Environ. Biophys., 2013, vol. 52, pp. 87–98.
Gong, P., Zhang, T., He, D., et al., MicroRNA-145 modulates tumor sensitivity to radiation in prostate cancer, Rad. Res., 2015, vol. 184, pp. 563–569.
Yang, Y., Xu, X., and Hao, Y., Research of the relationship between radiotherapy and microRNAs, J. Clin. Oncol., 2012, vol. 11, no. 5, pp. 285–289.
Xu, S., Wang, Y., Ding, N., et al., Exome-mediated microRNA transfer plays a role in radiation-induced bystander effect, RNA Biol., 2015, p. 1100795.
Mao, A., Liu, G., Zhang, H., et al., MicroRNA expression and biogenesis in cellular response to ionizing radiation, DNA Cell Biol., 2014, vol. 33, no. 10, pp. 667–679.
Dressman, H.K., Muramoto, G.G., Chao, N.J., et al., Gene expression signatures that predict radiation exposure in mice and humans, PLoS Med., 2007, vol. 4. e106
Bi, N., Schipper, M., Stanton, P., et al., Serum miRNA signature to identify a patient’s resistance to high-dose radiation therapy for unresectable non-small cell lung cancer, J. Clin. Oncol., 2013, vol. 31, pp. 75–80.
Ke, G., Liang, L., Yang, Y., et al., MiR181a confers resistance of cervical cancer to radiation therapy through targeting the proapoptopic PRKCD gene, Oncogene, 2013, vol. 32, pp. 3019–3027.
Girardi, C., Pitta, C., Casara, S., et al., Analysis of miRNA and mRNA expression profiles alterations in ionizing radiation response of human lymphocytes under modeled microgravity, PLoS One, 2012, vol. 7. e31293
Saleh, A.D., Savage, J.E., Cao, L., et al. Cellular stress induced alteration in microRNA let-7a and let-7b expression are dependent on p53, PLoS One, 2011, vol. 6. e24429
Zhang, J., Sun, Q., Zhang, Z., et al., Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancer by impairing the MDM2-p53 feedback loop, Oncogene, 2013, vol. 32, no. 1, pp. 61–69.
Le, M.T., The, C., et al., MicroRNA-125b a novel negative regulator of p53, Genes Dev., 2009, vol. 23, pp. 862–876.
Hu, W., Chan, C.S., Wu, R., et al., Negative regulation of tumor suppressor p53 by microRNA miR 504, Mol. Cell, 2010, vol. 38, no. 5, pp. 689–699.
Kumar, M., Lu, Z., Takwi, A.A., et al., Negative regulation of the tumor suppressor p53 gene be microRNAs, Oncogene, 2011, vol. 30, pp. 843–853.
Brachova, P., Mueting, S., Devor, E., et al., Oncomorphic TP53 mutations in gynecologic cancer lose the normal protein: protein interactions with microRNA microprocessing complex, J. Cancer Ther., 2014, vol. 5, pp. 506–516.
Mendell, J., miRiad roles for the miR-17–92 cluster in development and disease, Cell, 2008, vol. 133, pp. 217–222.
Mert, U., Ozgur, E., Tiryakioglu, D., et al., Induction of p-53-inducible microRNA-34 by gamma-radiation and bleomycin are different, Front. Genet., 2012, vol. 3, pp. 1–3.
Moskwa, P., Buffa, F., Pan, G., et al., miR-182–mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors, Mol. Cell, 2011, vol. 41, pp. 210–220.
Yan, D., Ng, W., Zhang, X., et al., Targeting DNAPKcs and ATM with miR-101 sensitized tumors to radiation, PLoS One, 2010, vol. 5. e11397
Wright, C., Dan, T., Dicker, A., et al., MicroRNAs: the shot link between cancer and RT-induced DNA damage respons, Front. Oncol., 2014, vol. 4, pp. 1–3.
Tarasov, V.A., Matishov, D.G., Shin, E.F., et al., Coordinated aberrant expression of miRNAs in colon cancer, Russ. J. Genet., 2014, vol. 50, no. 10, pp. 1090–1101.
Zhao, L., Bode, A., Cao, G., et al., Regulatory mechanisms and clinical perspectives of microRNA in tumor radiosensitive, Carcinogenesis, 2012, vol. 33, pp. 2220–2227.
Iorio, M.V., Ferrasin, M., Liu, C., et al., MicroRNA gene expression deregulation in human breast cancer, Cancer Res., 2005, vol. 65, pp. 7065–7070.
Bonci, D., Coppola, V., Musumeci, V., et al., The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities, Nat. Med., 2008, vol. 14, pp. 1271–1277.
Salnikova, L.E., Clinicopathologic characteristics of brain tumors are associated with the presence and patterns of TP53 mutations: evidence from the IARC TP53 Database, Neuromol. Med., 2014, vol. 16, pp. 431–447.
Nadiminty, N., Tummala, R., Lou, W., et al., MicroRNA let-7c suppressed androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells, J. Biol. Chem., 2012, vol. 287, no. 2, pp. 1527–1537.
Huang, X., Taeb, S., Jahangiri, S., et al., MicroRNA-95 mediates radioresistance in tumor by targeting the sphingolipid phosphatase SGPP1, Cancer Res., 2013, vol. 73, no. 23, pp. 6972–6986.
Arora, H., Qureshi, R., Jin, S., et al., Mir-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NF[kappa]B1, Exp. Mol. Med., 2011, vol. 43, pp. 298–304.
Shulenina, L.V., Galstyan, I.A., Nadezhdina, N.M., et al., The expression of mature miRNAs involved in the functioning of the p53-dependent system to preserve the stability of the genome in individuals exposed to clinically relevant doses, Sarat. Nauchno-Med. Zh., 2014, vol. 10, no. 4, pp. 5–14.
Li, B., Shi, X., Nori, D., et al., Down-regulated of microRNA106b is involved in pz1-mediated cell cycle arrest in response to radiation in prostate cancer cells, Prostate, 2011, vol. 71, pp. 567–574.
Shulenina, L.V., Mikhailov, V.F., Ledin, E.V., et al., Evaluating the effectiveness of the p53-dependent system of genome stability based on microRNA and mRNA content in the blood of cancer patients, Med. Radiol. Radiats. Bezop., 2015, vol. 60, no. 1, pp. 5–14.
Xu, S., Ding, N., Pei, H., et al., MiR-21 is involved in radiation-induced bystander effect, RNA Biol., 2014, vol. 11, pp. 1161–1170.
Skog, J., Wurdinger, T., Rijn, S., et al., Glioblastoma microvesicles transport RNA and proteins that promote tumor growth and provide diagnostic biomarkers, Nature, 2008, vol. 10, pp. 1470–1476.
Talor, D. and Geral-Talor, C., MicroRNA signature of tumor-derived exosomes as diagnostic biomarker of ovarian cancer, Ginecol. Oncol., 2008, vol. 110, pp. 13–21.
Ohshima, S., Inoue, K., Fujiwara, A., et al., Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cell line, PLoS One, 2010, vol. 5. e347
Zasukhina, G.D., Shagirova, Zh.M., Reutova, N.V., et al., The expression of genes that control cell homeostasis in patients with Down’s syndrome, Tekhnol. Zhivikh Syst., 2013, vol. 10, no. 7, pp. 38–44.
Zasukhina, G.D., Mikhailov, V.F., Vasil’eva, I.M., and Shulenina, L.V., The cells of patients with Down’s syndrome–a model for studying the mechanisms of carcinogenesis, hypersensitivity to gene toxicants, and antimutagenesis, Usp. Sovrem. Biol., 2016, vol. 136, no. 2, pp. 126–142.
Murley, J., Kataoka, G., Miller, R., et al., SOD-2 mediated effects induced by WR1065 and low-dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells, Rad. Res., 2011, vol. 175, pp. 57–65.
Artacho-Cordon, F., Rios-Arrabal, S., Olivares-Urbanj, M.A., et al., Valproic acid modulated radiation-enhanced matrix metalloproteinase activity and invasion of breast cancer cells, Int. J. Rad. Biol., 2015, vol. 91, no. 12, pp. 946–956.
Liao, J., Zhou, X., Zhang, Yu, et al., A new link of p53-family with cancer and Down syndrome, Cell Cycle, 2012, vol. 11, pp. 2624–2630.
Zasukhina, G.D., Vasil’eva, I.M., Shagirova, Zh.M., et al., Comparison of the effects of antimutagens and adapting factors in radioresistant and radiosensitive cells in connection with the protein and gene polymorphism, Tekhnol. Zhivikh Syst., 2009, vol. 6, no. 1, pp. 3–13.
Zasukhina, G.D., Semyachkina, A.N., Vasil’eva, I.M., et al., Comparison of the antimutagenic activities of natural and synthetic substances in irradiated repairdefective human cells, Dokl. Biol. Sci., 2006, vol. 408, no. 1–6, pp. 269–271.
Kralj, M., Tusec-Bozic, L., and Erkenec, L., Biomedical potentials of crawn ethers: prospective antitumor agents, Chem. Med. Chem., 2008, vol. 3, pp. 1478–1492.
Mikhailov, V.F., Shishkina, A.A., Vasilyeva, I.M., Zasukhina, G.D., Shulenina, L.V., Raeva, N.F., Rogozhin, E.A., Startsev, M.I., Zasukhina, G.D., Gromov, S.P., and Alfimov, M.V., Comparative analysis of natural and synthetic antimutagens as regulators of gene expression in human cells under exposure to ionizing radiation, Russ. J. Genet., 2015, vol. 51, no. 2, pp. 130–137.
Odintsova, T.I., Vasil’eva, I.M., Zasukhina, G.D., and Korostyleva, T.V., Antimutagenic activity of wheat ß-purothionin Tk-AMP-BP, Russ. J. Genet., 2011, vol. 47: 1128.
Rastogi, L., Feroz, S., Pandey, B., et al., Protection against radiation oxidative damage by an ethanolic extract of Nigella sativa L., Int. J. Biol., 2010, vol. 86, no. 9, pp. 719–731.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.F. Mikhailov, L.V. Shulenina, I.M. Vasilyeva, M.I. Startsev, G.D. Zasukhina, 2017, published in Genetika, 2017, Vol. 53, No. 3, pp. 265–278.
Rights and permissions
About this article
Cite this article
Mikhailov, V.F., Shulenina, L.V., Vasilyeva, I.M. et al. The miRNA as human cell gene activity regulator after ionizing radiation. Russ J Genet 53, 285–296 (2017). https://doi.org/10.1134/S1022795417020077
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795417020077


